- Home
- GE vs NVS Comparison
GE vs NVS Comparison
Compare GE & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GE
- NVS
- Stock Information
- Founded
- GE 1892
- NVS 1895
- Country
- GE United States
- NVS Switzerland
- Employees
- GE N/A
- NVS N/A
- Industry
- GE Consumer Electronics/Appliances
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- GE Technology
- NVS Health Care
- Exchange
- GE Nasdaq
- NVS Nasdaq
- Market Cap
- GE 299.3B
- NVS 242.8B
- IPO Year
- GE N/A
- NVS 1991
- Fundamental
- Price
- GE $281.61
- NVS $124.13
- Analyst Decision
- GE Strong Buy
- NVS Sell
- Analyst Count
- GE 10
- NVS 4
- Target Price
- GE $257.50
- NVS $119.00
- AVG Volume (30 Days)
- GE 4.0M
- NVS 1.1M
- Earning Date
- GE 10-21-2025
- NVS 10-28-2025
- Dividend Yield
- GE 0.51%
- NVS 2.09%
- EPS Growth
- GE 69.20
- NVS N/A
- EPS
- GE 7.17
- NVS 6.85
- Revenue
- GE $41,611,000,000.00
- NVS $55,186,000,000.00
- Revenue This Year
- GE $8.87
- NVS $9.01
- Revenue Next Year
- GE $11.28
- NVS $2.49
- P/E Ratio
- GE $40.17
- NVS $17.58
- Revenue Growth
- GE 13.06
- NVS 12.95
- 52 Week Low
- GE $159.36
- NVS $96.06
- 52 Week High
- GE $286.91
- NVS $130.46
- Technical
- Relative Strength Index (RSI)
- GE 61.74
- NVS 47.62
- Support Level
- GE $273.30
- NVS $126.09
- Resistance Level
- GE $286.91
- NVS $128.05
- Average True Range (ATR)
- GE 5.90
- NVS 1.14
- MACD
- GE 0.42
- NVS -0.47
- Stochastic Oscillator
- GE 73.96
- NVS 9.37
About GE General Electric Company
GE Aerospace is the global leader in designing, manufacturing, and servicing commercial aircraft engines, along with partner Safran in their CFM joint venture. With its massive global installed base of nearly 70,000 commercial and military engines, GE Aerospace earns most of its profits on recurring service revenue of that equipment, which operates for decades. GE Aerospace is the remaining core business of the company formed in 1892 with historical ties to American inventor Thomas Edison; that company became a storied conglomerate with peak revenue of $130 billion in 2000 until GE spun off its appliance, finance, healthcare, and wind and power businesses between 2016 and 2024.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.